Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: Differential diagnosis between refractory anemia and aplastic anemia-Reference-Cited by-同舟云学术

Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: Differential diagnosis between refractory anemia and aplastic anemia

Published:2008-06 Issue:6 Volume:58 Page:353-360
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathol Int

Author:

Iwasaki Takashi,Murakami Masashi,Sugisaki Chiho,Sobue Sayaka,Ohashi Haruhiko,Asano Haruhiko,Suzuki Motoshi,Nakamura Shigeo,Ito Masafumi,Murate Takashi

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1827.2008.02236.x/fullpdf

Reference26 articles.

1. Immune Pathophysiology of Aplastic Anemia

2. Immunosuppressive Treatments for Myelodysplastic Syndromes

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired haemoglobin F (HbF) in HbA1c analysis predating a diagnosis of myelodysplastic syndrome;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2023-12-05

2. Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome;International Journal of Hematology;2022-12-27

3. Relationship between p53 expression and prognosis of myelodysplastic syndrome treated with azacitidine;Journal of Hematopathology;2020-08-20

4. Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia;International Journal of Hematology;2019-03-07

5. PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY;Mediterranean Journal of Hematology and Infectious Diseases;2019-02-26